XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Series D Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Common Stock [Member]
Series D Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series D Convertible Preferred Stock [Member]
Retained Earnings [Member]
Series D Convertible Preferred Stock [Member]
AOCI Attributable to Parent [Member]
Series D Convertible Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Sep. 30, 2020             350 4,420,170        
Balance at Sep. 30, 2020             $ 0 $ 4 $ 78,316 $ (73,583) $ (381) $ 4,356
Stock-based compensation expense             0 0 51 0 0 51
Net income (loss)             0 0 0 (1,162) 0 (1,162)
Foreign currency translation             0 0 0 0 10 10
Stock-based compensation expense             0 0 51 0 0 51
Net income (loss)             0 0 0 (1,162) 0 (1,162)
Net change in foreign currency translation adjustment             $ 0 $ 0 0 0 10 10
Balance (in shares) at Dec. 31, 2020             350 4,420,170        
Balance at Dec. 31, 2020             $ 0 $ 4 78,367 (74,745) (371) 3,255
Balance (in shares) at Sep. 30, 2020             350 4,420,170        
Balance at Sep. 30, 2020             $ 0 $ 4 78,316 (73,583) (381) 4,356
Net income (loss)                       (5,327)
Foreign currency translation                       (45)
Net income (loss)                       (5,327)
Net change in foreign currency translation adjustment                       (45)
Balance (in shares) at Jun. 30, 2021             4,550 6,801,243        
Balance at Jun. 30, 2021             $ 0 $ 7 87,663 (78,910) (426) 8,334
Balance (in shares) at Dec. 31, 2020             350 4,420,170        
Balance at Dec. 31, 2020             $ 0 $ 4 78,367 (74,745) (371) 3,255
Stock-based compensation expense             $ 0 $ 0 39 0 0 39
Issuance of common stock –warrants exercised (in shares)             0 48,612        
Issuance of common stock –warrants exercised             $ 0 $ 0 140 0 0 140
Net income (loss)             0 0 0 (556) 0 (556)
Foreign currency translation             0 0 0 0 (69) (69)
Stock-based compensation expense             0 0 39 0 0 39
Net income (loss)             0 0 0 (556) 0 (556)
Net change in foreign currency translation adjustment             $ 0 $ 0 0 0 (69) (69)
Issuance of common stock – stock options exercised (in shares)             0 13,333        
Issuance of common stock – stock options exercised             $ 0 $ 0 19 0 0 19
Issuance of common stock – warrants exercised (in shares)             0 48,612        
Issuance of common stock – warrants exercised             $ 0 $ 0 140 0 0 140
Issuance of common stock, net of offering costs (in shares)             0 880,000        
Issuance of common stock, net of offering costs             $ 0 $ 1 2,461 0 0 2,462
Issuance of stock in connection with acquisition of business (in shares)             0 29,433        
Issuance of stock in connection with acquisition of business             $ 0 $ 0 99 0 0 99
Balance (in shares) at Mar. 31, 2021             350 5,391,548        
Balance at Mar. 31, 2021             $ 0 $ 5 81,125 (75,301) (440) 5,389
Stock-based compensation expense             $ 0 $ 0 43 0 0 43
Issuance of common stock –warrants exercised (in shares)             0 335,695        
Issuance of common stock –warrants exercised             $ 0 $ 1 2,176 0 0 2,177
Net income (loss)             0 0 0 (3,609) 0 (3,609)
Foreign currency translation             0 0 0 0 14 14
Stock-based compensation expense             0 0 43 0 0 43
Net income (loss)             0 0 0 (3,609) 0 (3,609)
Net change in foreign currency translation adjustment             $ 0 $ 0 0 0 14 14
Issuance of common stock – stock options exercised (in shares)             0 14,000        
Issuance of common stock – stock options exercised             $ 0 $ 0 20 0 0 20
Issuance of common stock – warrants exercised (in shares)             0 335,695        
Issuance of common stock – warrants exercised             $ 0 $ 1 2,176 0 0 2,177
Issuance of common stock, net of offering costs (in shares) 2,700 0         0 1,060,000        
Issuance of common stock, net of offering costs $ 0 $ 0 $ 1,377 $ 0 $ 0 $ 1,377 $ 0 $ 1 1,992 0 0 1,993
Issuance of stock in connection with acquisition of business (in shares) 1,500 0                    
Issuance of stock in connection with acquisition of business $ 0 $ 0 $ 930 $ 0 $ 0 $ 930            
Balance (in shares) at Jun. 30, 2021             4,550 6,801,243        
Balance at Jun. 30, 2021             $ 0 $ 7 87,663 (78,910) (426) 8,334
Balance (in shares) at Sep. 30, 2021             350 10,187,128        
Balance at Sep. 30, 2021             $ 0 $ 10 100,207 (82,287) (353) 17,577
Stock-based compensation expense             $ 0 $ 0 63 0 0 63
Issuance of common stock –warrants exercised (in shares)             0 17,148        
Issuance of common stock –warrants exercised             $ 0 $ 0 0 0 0 0
Net income (loss)             0 0 0 1,872 0 1,872
Foreign currency translation             0 0 0 0 41 41
Stock-based compensation expense             0 0 63 0 0 63
Net income (loss)             0 0 0 1,872 0 1,872
Net change in foreign currency translation adjustment             $ 0 $ 0 0 0 41 41
Issuance of common stock – warrants exercised (in shares)             0 17,148        
Issuance of common stock – warrants exercised             $ 0 $ 0 0 0 0 0
Balance (in shares) at Dec. 31, 2021             350 10,204,276        
Balance at Dec. 31, 2021             $ 0 $ 10 100,270 (80,415) (312) 19,553
Balance (in shares) at Sep. 30, 2021             350 10,187,128        
Balance at Sep. 30, 2021             $ 0 $ 10 100,207 (82,287) (353) 17,577
Net income (loss)                       2,620
Foreign currency translation                       107
Net income (loss)                       2,620
Net change in foreign currency translation adjustment                       107
Balance (in shares) at Jun. 30, 2022             350 10,217,609        
Balance at Jun. 30, 2022             $ 0 $ 10 100,590 (79,666) (246) 20,688
Balance (in shares) at Dec. 31, 2021             350 10,204,276        
Balance at Dec. 31, 2021             $ 0 $ 10 100,270 (80,415) (312) 19,553
Stock-based compensation expense             $ 0 $ 0 52 0 0 52
Issuance of common stock –warrants exercised (in shares)             0 13,333        
Issuance of common stock –warrants exercised             $ 0 $ 0 19 0 0 19
Net income (loss)             0 0 0 346 0 346
Foreign currency translation             0 0 0 0 42 42
Stock-based compensation expense             0 0 52 0 0 52
Net income (loss)             0 0 0 346 0 346
Net change in foreign currency translation adjustment             $ 0 $ 0 0 0 42 42
Issuance of common stock – warrants exercised (in shares)             0 13,333        
Issuance of common stock – warrants exercised             $ 0 $ 0 19 0 0 19
Balance (in shares) at Mar. 31, 2022             350 10,217,609        
Balance at Mar. 31, 2022             $ 0 $ 10 100,341 (80,069) (270) 20,012
Stock-based compensation expense             0 0 249 0 0 249
Net income (loss)             0 0 0 403 0 403
Foreign currency translation             0 0 0 0 24 24
Stock-based compensation expense             0 0 249 0 0 249
Net income (loss)             0 0 0 403 0 403
Net change in foreign currency translation adjustment             $ 0 $ 0 0 0 24 24
Balance (in shares) at Jun. 30, 2022             350 10,217,609        
Balance at Jun. 30, 2022             $ 0 $ 10 $ 100,590 $ (79,666) $ (246) $ 20,688